Tufts CSDD: CNS Drugs Longer to Develop; Lower Success Rates

Drugs that treat central nervous system (CNS) diseases take more than a year longer to develop and are less than half as likely to obtain marketing approval than other drugs, according to a newly completed study by the Tufts Center for the Study of Drug Development. Mean clinical development tOriginal Article